ESR and FAI aim to give farmers the tools and knowledge needed to assess and improve tilapia welfare and enhance fish performance.

The model is designed to accelerate research into vaccines and feed additives for this important cause of mortality in farmed salmon, or the identification of genetically resistant strains.

The company plans to build a RAS broodstock and hatchery center, complementing the existing RAS nursery operations.

The line is selected for fast growth and also combines robustness, resistance to specific pathogens and a competitive fillet yield.

Applications of precision breeding techniques, and particularly gene editing, have transformative potential to tackle some challenges facing salmon farming today.

The Chilean company plans to expand its technology to shrimp farms after being successfully applied in salmon farms.

Jens Jensen will oversee the expansion of sales activities across key international markets.

The update will come into effect introducing over 300 new standards and amendments.

The proposed sanitary conditions will reduce the risk of introducing pathogens in Peru from companies in Northern Ireland.

The Bureau of Fisheries and Aquatic Resources is set to sign an agreement with the Bohol provincial government for the construction of a tilapia hatchery that will boost the fish supply on the island.

The facility can simulate conditions that farmers experience in different hatcheries around the world and do trials with both marine and freshwater larvae.

A project to produce 20,000 finfish per year and a partnership with Pure Salmon were unveiled by NEOM food company.

The aqua business of Elanco Animal Health consists of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species; two related aqua manufacturing facilities in Canada and Vietnam; as well as a research facility in Chile.

Greater amberjack (Seriola dumerilii) like other marine fish species shows high rates of deformities, which are related to the poor production efficiency during the hatchery phase.

The initiative received partial research support from the Government of Bangladesh and was funded by the World Bank.

A novel antimicrobial protein and treatment regimen was developed that specifically kills only Streptococcus bacteria, and does not leave any chemical residues in the environment.

WorldFish provided 14,000 18th-generation Genetically Improved Farmed Tilapia (GIFT) fry to the Jitra Aquaculture Extension Center in Malaysia.

Contrary to earlier belief, scientists discovered that fish develop an antibody response in structures located in the spleen.

Fluctus will supply water-feeding systems for its RAS facility in Japan.

Tests using traditional methods for administering salmon lice vaccines via injection have shown limited success.